superselective adrenal arterial embolization

PROCEDURE3 trials

Sponsors

Second Affiliated Hospital of Nanchang University, Chinese Academy of Medical Sciences, Fuwai Hospital

Conditions

Essential HypertensionHyperaldosteronismIdiopathic HyperaldosteronismPrimary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)

Unknown Phase

Superselective Adrenal Arterial Embolization for Bilateral Idiopathic Hyperaldosteronism: A Prospective Cohort Study

Second Affiliated Hospital of Nanchang UniversityPrimary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)

Start: 2022-01-01End: 2022-12-31Target: 50Updated: 2022-07-21

Superselective Adrenal Arterial Embolization for Refractory Hypertension: A Proof-of-Concept Study

RecruitingNCT06568640

Second Affiliated Hospital of Nanchang UniversityEssential Hypertension

Start: 2024-08-01End: 2027-12-31Target: 20Updated: 2024-08-23

Superselective Adrenal Arterial Embolization Versus Oral Spironolactone for Treatment of Idiopathic Hyperaldosteronism

RecruitingNCT07328230

Chinese Academy of Medical Sciences, Fuwai HospitalHyperaldosteronism, Idiopathic Hyperaldosteronism

Start: 2022-08-01End: 2025-12-31Target: 172Updated: 2026-01-09